how long glp 1 been around drugs have they History of glucagon-like peptide- 1 receptor agonists GLP-1 Genetics: How Genes Affect – GLP-1 medications were first introduced

One of the most common side effects reported for all GLP-1R agonists is malaise (Kanoski et al., 2012)

it is a modified fragment of human growth hormone (HGH) that targets fat metabolism while minimizing effects on blood sugar and growth processes, making it a valuable tool for experimental studies in obesity and metabolic research

2 Notably, the FDA awarded the first gene editing approval to CRISPR Therapeutics and Vertex Pharmaceuticals Casgevy

doi: 10.1016/j.clicom.2023.07.001 8 LeeH-JKimM

These drugs are approved to treat different conditions, including obesity and type 2 diabetes, and are now being tested for treatments far beyond obesity and diabetes

Understanding storage conditions protects both your investment and your results